๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-02-25

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial (NCT05581303)

A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)

๐Ÿ”ต Active, Not Recruiting Phase3 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Amgen

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The primary objective of this trial is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants with atherosclerotic cardiovascular disease (ASCVD) and elevated Lipoprotein(a).

Who can join: Review the eligibility criteria below.

Location: Ascension Saint Vincents Birmingham โ€” Birmingham, Alabama

Age range: 18 Years to 85 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (737 Sites)

Showing the first 25 of 737 sites.

  • Ascension Saint Vincents Birmingham โ€” Birmingham, Alabama
  • Grandview Medical Center Affinity Cardiovascular Specialists, LLC โ€” Birmingham, Alabama
  • Heart Center Research LLC โ€” Huntsville, Alabama
  • Mobile Heart Specialists PC โ€” Mobile, Alabama
  • Alaska Cardiovascular Research Foundation โ€” Anchorage, Alaska
  • Elite Clinical Studies LLC โ€” Phoenix, Arizona
  • HonorHealth Research and Innovation Institute โ€” Scottsdale, Arizona
  • National Heart Institute โ€” Beverly Hills, California
  • Vitality Clinical Research โ€” Beverly Hills, California
  • University of California San Diego โ€” La Jolla, California
  • VA Greater Los Angeles Healthcare System โ€” Los Angeles, California
  • University of California Irvine โ€” Orange, California
  • University of California Los Angeles โ€” Santa Monica, California
  • Manshadi Heart Institute โ€” Stockton, California
  • Med Partners, Inc dba Premiere Medical Center, Inc โ€” Toluca Lake, California
  • UCHealth Memorial Central โ€” Colorado Springs, Colorado
  • Cardiology Associates of Fairfield County PC โ€” Stamford, Connecticut
  • MedStar Clinical Research โ€” Washington D.C., District of Columbia
  • Excel Medical Clinical Trials โ€” Boca Raton, Florida
  • Bay Area Cardiology โ€” Brandon, Florida
  • Clearwater Cardiovascular Consultants โ€” Clearwater, Florida
  • Cardiology Associates Research LLC โ€” Daytona Beach, Florida
  • Jellinger and Lerman MD PA dba The Center for Diabetes and Endocrine Care โ€” Fort Lauderdale, Florida
  • Elite Cardiac Research Center LLC โ€” Hialeah, Florida
  • East Coast Institute for Research, LLC โ€” Jacksonville, Florida

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—